Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP) has released an update. Beximco Pharmaceuticals Limited is set to hold its 48th Annual General Meeting virtually on December 29, 2024, where shareholders
Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP) has released an update. Beximco Pharmaceuticals Limited is set to hold its 48th Annual General Meeting virtually on December 29, 2024, where shareholders
Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP) has released an update. Beximco Pharmaceuticals Limited has reported modest revenue growth for the first quarter ending September 2024, despite ongoing macroeconomic challenges.
Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP) has released an update. Beximco Pharmaceuticals Limited has successfully appealed to the Bangladesh Supreme Court, leading to the immediate lifting of its trading
Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP) has released an update. Beximco Pharmaceuticals Limited has temporarily suspended trading of its shares on AIM due to a pending Supreme Court decision
Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP) has released an update. Beximco Pharmaceuticals Limited reported a notable 13.1% increase in net sales for the year ending June 2024, reaching BDT